Search

everythinglearnresearchcommunity

for

Search:↓

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Alitretinoin can effectively treat frontal fibrosing alopecia.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Use a combination of oral dutasteride, topical treatments, and hydroxychloroquine to manage frontal fibrosing alopecia.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

MK-5108 is safe and shows potential against tumors, especially alone.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Oral dutasteride is a recommended first treatment for frontal fibrosing alopecia.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.